ResMed Inc.
RMD
$251.69
$3.111.25%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.31B | 1.25B | 1.11B | 1.02B | 958.38M |
| Total Depreciation and Amortization | 190.39M | 192.62M | 189.56M | 188.76M | 188.98M |
| Total Amortization of Deferred Charges | 25.89M | 26.39M | 26.92M | 27.45M | 27.68M |
| Total Other Non-Cash Items | 108.30M | 84.95M | 116.18M | 119.32M | 98.88M |
| Change in Net Operating Assets | 15.11M | -76.36M | -5.03M | 44.78M | -75.33M |
| Cash from Operations | 1.65B | 1.48B | 1.44B | 1.40B | 1.20B |
| Capital Expenditure | -84.16M | -84.56M | -87.27M | -99.46M | -109.03M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -20.37M | -23.45M | -30.28M | -133.46M | -115.29M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.31M | -6.21M | -1.11M | -36.86M | -45.48M |
| Cash from Investing | -112.84M | -114.21M | -118.66M | -269.78M | -269.80M |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 105.00M | 105.00M |
| Total Debt Repaid | -335.00M | -555.00M | -680.00M | -835.00M | -680.00M |
| Issuance of Common Stock | 71.98M | 67.85M | 60.49M | 53.09M | 48.89M |
| Repurchase of Common Stock | -267.93M | -242.85M | -208.94M | -158.77M | -108.68M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -303.84M | -296.63M | -289.61M | -282.32M | -276.47M |
| Other Financing Activities | -855.00K | -855.00K | -855.00K | -1.29M | -3.34M |
| Cash from Financing | -835.65M | -1.03B | -1.12B | -1.12B | -914.60M |
| Foreign Exchange rate Adjustments | -9.65M | -22.91M | 14.32M | -1.72M | -4.17M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 694.80M | 311.70M | 217.26M | 10.47M | 10.02M |